A number of stocks fell in the afternoon session after the release of a stronger-than-anticipated Producer Price Index (PPI) report showed wholesale inflation rose more than expected in January.
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the investment banking & brokerage stocks, including Stifel (NYSE:SF) and its peers.
A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south.
While some investors embrace risk, mistakes can be costly for those who aren’t prepared.
While profitability is essential, it doesn’t guarantee long-term success.
Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".
Stifel’s fourth quarter results exceeded Wall Street’s expectations, with management attributing the outperformance to strength in both its Global Wealth Management and Institutional segments. CEO Ronald James Kruszewski emphasized that record adviser recruiting and strong client activity underpinned the firm’s revenue growth, while the institutional business benefited from robust investment banking, particularly in advisory and capital markets. CFO James Marischen noted that operating leverage and disciplined expense control also played a significant role in delivering higher profitability, as compensation and non-compensation expenses remained well aligned with revenue growth. The quarter’s performance was further bolstered by increased client assets, a resilient balance sheet, and elevated activity in key sectors such as healthcare and financials.
Financial services firm Stifel Financial (NYSE:SF) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 14.4% year on year to $1.56 billion. Its non-GAAP profit of $2.63 per share was 4.8% above analysts’ consensus estimates.
Financial services firm Stifel Financial (NYSE:SF) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 14.4% year on year to $1.56 billion. Its non-GAAP profit of $2.71 per share was 8% above analysts’ consensus estimates.
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets.
But the many opportunities in front of them attract significant competition, spanning from industry behemoths with seemingly infinite resources to small, nimble players with chips on their shoulders.
On Friday, January 16, 2026, Micron Technology (NASDAQ: MU) shares ignited a massive rally, surging 7.7% to reach a fresh all-time high of $368.50. This leap, which continued to stabilize through the morning of January 20, marks a definitive shift in the semiconductor landscape, as the "memory supercycle"
The stocks in this article are all trading near their 52-week highs.
This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial performance.
The first week of 2026 has set the biotech sector ablaze, with Revolution Medicines (NASDAQ: RVMD) finding itself at the epicenter of a high-stakes acquisition tug-of-war. Shares of the Redwood City-based oncology specialist experienced a roller-coaster session following reports that Big Pharma titan AbbVie (NYSE: ABBV) was in advanced discussions
A cash-heavy balance sheet is often a sign of strength, but not always.
Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow.
In a move that signals no slowing down for the white-hot wealth management sector, Mariner Wealth (formerly Mariner Wealth Advisors) has officially announced the dual acquisition of First National Advisors and Strava Wealth. The transaction, which finalized as the calendar turned to 2026, integrates approximately $1.8 billion in total
